Cart
sales@molnova.com
NIK SMI1
CAS No. 1660114-31-7
NIK SMI1( NIK SMI1 | NIKSMI1 | NIK-SMI1 )
Catalog No. M12533 CAS No. 1660114-31-7
NIK SMI1 is a potent, selective small molecule inhibitor of NF-κB inducing kinase (NIK) with Ki of 230±170 pM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 410 | In Stock |
|
| 5MG | 174 | In Stock |
|
| 10MG | 281 | In Stock |
|
| 25MG | 563 | In Stock |
|
| 50MG | 867 | In Stock |
|
| 100MG | 1395 | In Stock |
|
| 200MG | 1907 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNIK SMI1
-
NoteResearch use only, not for human use.
-
Brief DescriptionNIK SMI1 is a potent, selective small molecule inhibitor of NF-κB inducing kinase (NIK) with Ki of 230±170 pM.
-
DescriptionNIK SMI1 is a potent, selective small molecule inhibitor of NF-κB inducing kinase (NIK) with Ki of 230±170 pM; only inhibits 3 out of 222 off-target kinases (KHS1, LRRK2, and PKD1) with >75% inhibition at 1 uM; potently inhibits anti-LTβR-induced nuclear p52 levels in anti-LTβR-stimulated HeLa cells, with no effect on canonical signaling; inhibits BAFF and CD40 signaling, suppresses immune responses in vivo; suppresses disease biomarkers and improves survival and renal function in NZB/W F1 mice.
-
In Vitro——
-
In Vivo——
-
SynonymsNIK SMI1 | NIKSMI1 | NIK-SMI1
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1660114-31-7
-
Formula Weight365.389
-
Molecular FormulaC20H19N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 273.69 mM
-
SMILESO=C(N)C1=NC(C2=CC=CC(C#C[C@@]3(O)C(N(C)CC3)=O)=C2)=CC(OC)=C1
-
Chemical Name(R)-6-(3-((3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)-4-methoxypicolinamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Brightbill HD, et al. Nat Commun. 2018 Jan 12;9(1):179.
molnova catalog
related products
-
JSH-23
JSH-23 is an inhibitor of NF-κB transcriptional activity with IC50 of 7.1 μM.
-
(R)-(-)-Ibuprofen
An enantiomer of Ibuprofen that is generally not considered a COX inhibitor and is instead thought to be involved in pathways of lipid metabolism as it is incorporated into triglycerides along with fatty acids.
-
SR12460
SR12460 (SR-12460) is a novel NF-κB essential modulator (NEMO)-binding domain (NBD) mimetic for inhibiting IKK/NF-κB activation.
